Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.71 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.71 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.71 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.44 |
| ▸ | AXL | P30530 | 1/20 | 0.44 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.44 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17808036 | 0.99 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL19397412 | 0.99 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17918026 | 0.99 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17808163 | 0.99 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL19650625 | 0.99 | CYP11B2 (0.69) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL30296921 | 0.97 | CYP11B2 (0.68) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17808140 | 0.97 | CYP11B2 (0.68) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL21725413 | 0.97 | CYP11B2 (0.68) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17808137 | 0.97 | CYP11B2 (0.68) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 | |
| SCHEMBL17918135 | 0.97 | CYP11B2 (0.68) | CYP11B2CYP11B1CYP19A1CYP17A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11158811-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| EP-3220437-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20200303658-A1 | PYRIMIDINE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-09-24 | — | — | US | disclosed |
| US-10593884-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| US-10276800-B2 | Organic electroluminescence device having at least an a node, a hole injection layer, a first hole transport layer. A second hole transport layer a luminous layer, an electron transport layer, and a cathode | HODOGAYA CHEMICAL CO., LTD. (JP) | 2019-04-30 | — | — | US | disclosed |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-20170346015-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-11-30 | — | — | US | disclosed |
| US-20170346015-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-11-30 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170317291-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-11-02 | — | — | US | disclosed |
| EP-3220437-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2017-09-20 | — | — | EP | disclosed |
| US-20170186967-A1 | PYRIMIDINE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186967-A1 | PYRIMIDINE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| EP-3156402-A1 | PYRIMIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2017-04-19 | — | — | EP | disclosed |
| WO-2016111254-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 保土谷化学工業株式会社 | 2016-07-14 | — | — | WO | disclosed |
| WO-2016088759-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 保土谷化学工業株式会社 | 2016-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10276800-B2 | Organic electroluminescence device having at least an a node, a hole injection layer, a first hole transport layer. A second hole transport layer a luminous layer, an electron transport layer, and a cathode | SLC29A1, SLC29A2, NUDT1 | CYP11B2 1707/4885CYP11B1 1848/4885CYP19A1 1602/4885 |
| US-10593884-B2 | Organic electroluminescent device | AHR, SLC18A1, KCNH1 | CYP11B2 470/4885CYP11B1 272/4885CYP19A1 42/4885 |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, KCNH1 | CYP11B2 470/4885CYP11B1 272/4885CYP19A1 42/4885 |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, ARNT | CYP11B2 394/4885CYP11B1 450/4885CYP19A1 177/4885 |
| US-20170186967-A1 | PYRIMIDINE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | TYMS, UMPS, DPYD | CYP11B2 2329/4885CYP11B1 1800/4885CYP19A1 1535/4885 |
| US-20200303658-A1 | PYRIMIDINE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | TYMS, UMPS, DPYD | CYP11B2 2329/4885CYP11B1 1800/4885CYP19A1 1535/4885 |
| US-20170317291-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | NUDT1, SLCO4C1, SLC7A5 | CYP11B2 1456/4885CYP11B1 1637/4885CYP19A1 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.